US2006252695A1PendingUtilityA1

Analysis and separation of platelet-derived growth factor proteins

Assignee: CHIRON CORPPriority: Dec 13, 1996Filed: Jul 7, 2006Published: Nov 9, 2006
Est. expiryDec 13, 2016(expired)· nominal 20-yr term from priority
A61L 2300/414C07K 2319/02C07K 14/49C12N 15/81A61K 38/1858C07K 14/65A61P 19/08A61P 17/02A61K 9/06A61K 9/0014A61L 26/0066
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for improving purification and quantification of platelet derived growth factor (PDGF) proteins having structural heterogeneity are provided. Preparation of substantially pure isoforms of these proteins is achieved using TSK sulfopropyl cation exchange chromatography and reverse phase high performance liquid chromatography. A reverse charged capillary zone electrophoresis method enables quantification of substantially pure isoforms of these proteins resulting from endoproteolytic post-translational modifications. Compositions of the invention are substantially purified isoforms of secreted PDGF proteins having structural heterogeneity, more particularly purified intact, single-clipped, and double-clipped isoforms of recombinant PDGF-BB. Pharmaceutical compositions comprising at least one of these substantially purified recombinant PDGF isoforms and methods for their use in promoting wound healing are also provided.

Claims

exact text as granted — not AI-modified
1 . A method for preparing a composition enriched in at least one desired isoform of biologically active recombinant PDGF (rPDGF) dimeric protein or variant thereof from a mixture of isoforms of said rPDGF dimeric protein or variant thereof, said method comprising taking said mixture and enriching said mixture in said desired isoform by reducing amounts of undesired isoforms in said mixture to obtain said composition.  
   
   
       2 . The method of  claim 1 , wherein said enriching is accomplished using ion exchange chromatography, reverse phase high-pressure liquid chromatography, or reverse charge capillary zone electrophoresis.  
   
   
       3 . The method of  claim 2 , wherein said rPDGF dimeric protein is rPDGF-BB, wherein the rPDGF-B polypeptides in said rPDGF-BB are native-sequence or variant rPDGF-B polypeptides that exhibit at least about 80% sequence identity to native-sequence rPDGF-B polypeptides.  
   
   
       4 . The method of  claim 3 , wherein the rPDGF-B polypeptides are native-sequence polypeptides.  
   
   
       5 . The method of  claim 4 , wherein the rPDGF-B polypeptides have the amino acid sequences of human rPDGF-B polypeptides.  
   
   
       6 . The method of  claim 3 , wherein said rPDGF-BB is produced in a yeast host cell.  
   
   
       7 . The method of  claim 6 , wherein said yeast host cell is a  Saccharomyces  yeast host cell.

Join the waitlist — get patent alerts

Track US2006252695A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.